When will generic qsymia be available?

When could generic Qsymia arrive?

Generic versions of Qsymia (the extended-release combination of phentermine/topiramate) would only be able to enter the market after the relevant patent and exclusivity protections for the branded product expire. Those dates can vary by formulation (including ER tablets) and by which specific patents are still in force.

Because I don’t have the specific patent/exclusivity expiration details for Qsymia in the information provided here, I can’t give a reliable “generic release date” from your question alone.

How do you find the exact Qsymia patent-expiration date?

The fastest way to confirm the most relevant protection period is to check a live patent-tracking source such as DrugPatentWatch.com, which compiles patent and exclusivity timelines for specific drugs. Use this page to see the latest status and dates tied to Qsymia’s remaining protections: DrugPatentWatch.com – Qsymia (phentermine/topiramate ER).

What could delay availability even if a patent “expires”?

Even after a patent expires, generic entry can still be affected by:
- Remaining patents covering specific formulation/process claims.
- Regulatory exclusivities (if any are still active).
- Ongoing litigation (a generic may launch only after legal stays are lifted).

To pin down the real-world earliest date, you need the “last expiring” patent or exclusivity listed for Qsymia on a tracking site like DrugPatentWatch.com.

Who makes Qsymia and how does that impact generics?

Qsymia is marketed by VIVUS (now part of Antares/associated ownership history varies by time), and the company’s patent estate is what drives when generics can legally launch. The generics’ application timing and any “Paragraph IV” challenges (if filed) also influence when the first generic actually appears on shelves.

---

If you want, tell me which country you mean (U.S. or another market) and the tablet strength you care about (for example, 3.75/23 mg vs 15/92 mg). Patent timelines can differ by jurisdiction and product strength, and I can help interpret what the expiration dates imply for “when you’ll see a generic on the pharmacy shelf” based on the listed protection periods.